Asthma is not a risk factor for severity of SARS-CoV-2 infection in the Mexican population

References

• World Health Organization. Weekly operational update on COVID-2019. Available at: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19-19-october-2021. Accessed Oct 19, 2021.
   Google Scholar
• Giannouchos TV, Sussman RA, Mier JM, Poulas K, Farsalinos K. Characteristics and risk factors for COVID-19 diagnosis and adverse outcomes in Mexico: an analysis of 89,756 laboratory-confirmed COVID-19. Eur Respir J. 2021;57(3):2002144. doi:10.1183/13993003.02144-2020.
   Web of Science ®Google Scholar
• Denova-Gutiérrez E, Lopez-Gatell H, Alomia-Zegarra JL, et al. The association of obesity, type 2 diabetes, and hypertension with severe coronavirus disease 2019 on admission among Mexican patients. Obesity (Silver Spring). 2020. doi:10.1002/oby.22946.
   PubMed Web of Science ®Google Scholar
• Zhang Y, The Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19)—China. 2020;2:113–122. doi:10.46234/ccdcw2020.032.
   Google Scholar
• Novak N, Cabanillas B. Viruses and asthma: the role of common respiratory viruses in asthma and its potential meaning for SARS-CoV-2. Immunology. 2020;161(2):83–93. doi:10.1111/imm.13240.
   PubMed Web of Science ®Google Scholar
• Li X, Xu S, Yu M, Wang K, Tao Y, Zhou Y, Shi J, Zhou M, Wu B, Yang Z, et al. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. J Allergy Clin Immunol. 2020;146(1):110–118. doi:10.1016/j.jaci.2020.04.006.
   PubMed Web of Science ®Google Scholar
• Zhang J-j, Dong X, Cao Y-y, Yuan Y-d, Yang Y-b, Yan Y-q, Akdis CA, Gao Y-d. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy. 2020;75(7):1730–1741. doi:10.1111/all.14238.
   PubMed Web of Science ®Google Scholar
• Zhu Z, Hasegawa K, Ma B, Fujiogi M, Camargo CA, Jr, Liang L. Association of asthma and its genetic predisposition with the risk of severe COVID-19. J Allergy Clin Immunol. 2020; S0091-6749(20):30806–3080X. doi:10.1016/j.jaci.2020.06.001.
   Web of Science ®Google Scholar
• Yang JM, Koh HY, Moon SY, et al. Allergic disorders and susceptibility to and severity of COVID-19: a nationwide cohort study. J Allergy Clin Immunol. 2020;S0091-6749(20):31132–31136. doi:10.1016/j.jaci.2020.08.008.
   Web of Science ®Google Scholar
• Grandbastien M, Piotin A, Godet J, et al. SARS-CoV-2 pneumonia in hospitalized asthmatic patients did not induce severe exacerbation. J Allergy Clin Immunol Pract. 2020;S2213-2198(20):30667–3066X. doi:10.1016/j.jaip.2020.06.032.
   Web of Science ®Google Scholar
• Beurnier A, Jutant E-M, Jevnikar M, Boucly A, Pichon J, Preda M, Frank M, Laurent J, Richard C, Monnet X, et al. Characteristics and outcomes of asthmatic patients with COVID-19 pneumonia who require hospitalisation. Eur Respir J. 2020;56(5):2001875. doi:10.1183/13993003.01875-2020.
   PubMed Web of Science ®Google Scholar
• Mahdavinia M, Foster KJ, Jauregui E, Moore D, Adnan D, Andy-Nweye AB, Khan S, Bishehsari F. Asthma prolongs intubation in COVID-19. J Allergy Clin Immunol Pract. 2020;8(7):2388–2391. doi:10.1016/j.jaip.2020.05.006.
   PubMed Web of Science ®Google Scholar
• Chhiba KD, Patel GB, Vu THT, Chen MM, Guo A, Kudlaty E, Mai Q, Yeh C, Muhammad LN, Harris KE, et al. Prevalence and characterization of asthma in hospitalized and nonhospitalized patients with COVID-19. J Allergy Clin Immunol. 2020;146(2):307–314.e4. doi:10.1016/j.jaci.2020.06.010.
   PubMed Web of Science ®Google Scholar
• Lieberman-Cribbin W, Rapp J, Alpert N, Tuminello S, Taioli E. The impact of asthma on mortality in patients with COVID-19. Chest. 2020;S0012-3692(20):31645–31647. doi:10.1016/j.chest.2020.05.575.
   Web of Science ®Google Scholar
• Borobia A, Carcas A, Arnalich F, Álvarez-Sala R, Monserrat-Villatoro J, Quintana M, Figueira J, Torres Santos-Olmo R, García-Rodríguez J, Martín-Vega A, On behalf of the COVID@HULP Working Group, et al. A cohort of patients with COVID-19 in a major teaching hospital in Europe. JCM. 2020;9(6):1733. doi:10.3390/jcm9061733.
   Web of Science ®Google Scholar
• Sunjaya AP, Allida SM, Tanna D, Jenkins GL. C. Asthma and risk of infection, hospitalization, ICU admission and mortality from COVID-19: systematic review and meta-analysis. J Asthma. 2021;1–14. doi:10.1080/02770903.2021.1888116.
   PubMed Web of Science ®Google Scholar
• Sunjaya AP, Allida SM, Di Tanna GL, Jenkins CR. Asthma and coronavirus disease 2019 risk: a systematic review and meta-analysis. Eur Respir J. 2021;2101209. doi:10.1183/13993003.01209-2021.
   Web of Science ®Google Scholar
• Peters MC, Sajuthi S, Deford P, Christenson S, Rios CL, Montgomery MT, Woodruff PG, Mauger DT, Erzurum SC, Johansson MW, et al. COVID-19-related genes in sputum cells in asthma. Relationship to demographic features and corticosteroids. Am J Respir Crit Care Med. 2020;202(1):83–90. doi:10.1164/rccm.202003-0821OC.
   PubMed Web of Science ®Google Scholar
• Jackson DJ, Busse WW, Bacharier LB, Kattan M, O’Connor GT, Wood RA, Visness CM, Durham SR, Larson D, Esnault S, et al. Association of respiratory allergy, asthma, and expression of the SARS-CoV-2 receptor ACE2. J Allergy Clin Immunol. 2020;146(1):203–206.e3. doi:10.1016/j.jaci.2020.04.009.
   PubMed Web of Science ®Google Scholar
• Kimura H, Francisco D, Conway M, Martinez FD, Vercelli D, Polverino F, Billheimer D, Kraft M. Type 2 inflammation modulates ACE2 and TMPRSS2 in airway epithelial cells. J Allergy Clin Immunol. 2020;146(1):80–88.e8. doi:10.1016/j.jaci.2020.05.004.
   PubMed Web of Science ®Google Scholar
• Pujadas E, Chaudhry F, McBride R, et al. SARS-CoV-2 viral load predicts COVID-19 mortality. Lancet Respir Med. 2020;8(9):e70. doi:10.1016/S2213-2600(20)30354-4.
   PubMed Web of Science ®Google Scholar
• Edwards MR, Strong K, Cameron A, Walton RP, Jackson DJ, Johnston SL. Viral infections in allergy and immunology: how allergic inflammation influences viral infections and illness. J Allergy Clin Immunol. 2017;140(4):909–920. doi:10.1016/j.jaci.2017.07.025.
   PubMed Web of Science ®Google Scholar
• Díaz de León-Martínez L, de la Sierra-de la Vega L, Palacios-Ramírez A, Rodriguez-Aguilar M, Flores-Ramírez R. Critical review of social, environmental and health risk factors in the Mexican indigenous population and their capacity to respond to the COVID-19. Sci Total Environ. 2020;733:139357. doi:10.1016/j.scitotenv.2020.139357.
   PubMed Web of Science ®Google Scholar
• García-Sancho C, Fernández-Plata R, Martínez-Briseño D, Franco-Marina F, Pérez-Padilla JR. Prevalencia y riesgos asociados con pacientes adultos con asma de 40 años o más de la Ciudad de México: estudio de base poblacional. Salud Pública Méx. 2012;54(4):425–432. doi:10.1590/S0036-36342012000400013.
   PubMed Web of Science ®Google Scholar
• Del-Rio-Navarro BE, Navarrete-Rodríguez EM, Berber A, Reyes-Noriega N, García-Marcos Álvarez L, Grupo GAN México, Grupo ISAAC México. The burden of asthma in an inner-city area: a historical review 10 years after Isaac. World Allergy Organ J. 2020;13(1):100092. doi:10.1016/j.waojou.2019.100092.
   PubMed Web of Science ®Google Scholar
• Usman MS, Siddiqi TJ, Khan MS, Patel UK, Shahid I, Ahmed J, Kalra A, Michos ED. Is there a smoker’s paradox in COVID-19? BMJ Evid Based Med. 2020;bmjebm-2020-111492. doi:10.1136/bmjebm-2020-111492.
   Google Scholar